Publications by authors named "Rahat A Memon"
Article Synopsis
- This study examined sex differences in patients with cardiac sarcoidosis (CS) undergoing implantable cardioverter-defibrillator (ICD) implantation, using data from the National Inpatient Sample between 2016-2020.
- It was found that the majority of patients were male, who were generally younger and had higher rates of diabetes and chronic kidney disease, but lower rates of certain heart conditions compared to females.
- Although initial major adverse cardiovascular events (MACE) were higher in females, adjusted analyses showed that females actually had lower odds of experiencing MACE and acute kidney injury post-ICD compared to males.
Introduction: Sarcoidosis is a systemic inflammatory disorder characterised by non-caseating granulomas. Cardiac sarcoidosis (CS) normally causes conduction abnormalities, ventricular arrhythmias, and heart failure. Little is known about the characteristics and impact of sarcoidosis in patients admitted with ST-elevation myocardial infarction (STEMI).
View Article and Find Full Text PDFIntroduction: While the exact pathogenesis of peripartum cardiomyopathy, a potentially life-threatening condition, is still unknown, its incidence is rising globally. We sought to understand the differences in outcomes and complications based on age.
Methods: Records from the 2016-2020 National Inpatient Sample were used for our study.
Racial Disparities in Mortality Among Non-Hispanic Whites, Asian-American/Pacific Islanders, and Hispanics After Percutaneous Coronary Intervention in the Prepandemic and Peak-Pandemic Era in the United States.
Am J Cardiol
November 2023
Differences in Outcomes of Transcatheter Aortic Valve Replacement Compared With Surgical Aortic Valve Replacement in 100,995 Patients With Obesity across the United States.
Am J Cardiol
September 2023
The effectiveness of polypill therapy in the prevention and treatment of cardiovascular disorders is still unclear. This meta-analysis aimed to assess the efficacy of polypill therapy in reducing cardiovascular risk factors. We conducted a systematic search of PubMed, Cochrane CENTRAL, SCOPUS, and Google Scholar for randomized controlled trials (RCTs) that evaluated polypill therapy for cardiovascular diseases, hypertension, or dyslipidemia.
View Article and Find Full Text PDFArticle Synopsis
- Polypills improve medication adherence and clinical outcomes for patients at high risk of cardiovascular diseases (CVD), according to a recent meta-analysis of six randomized control trials involving over 13,000 participants.
- The analysis, which followed PRISMA guidelines, found that patients taking polypills showed significantly better adherence rates (RR: 1.38) and a reduced risk of cardiovascular events (RR: 0.72) compared to those in the control group.
- However, no significant differences were observed in LDL-C and total cholesterol levels between the polypill and control groups, indicating that the primary benefits relate to adherence and event reduction rather than cholesterol change.
Atrial fibrillation is an irregular heart rhythm, and it is one of the most common cardiac arrhythmias. It is associated with a five times increase in the risk of stroke. Anti-coagulants are prescribed routinely to prevent strokes, especially in patients with atrial fibrillation for many years decreasing the risk of stroke among patients with atrial fibrillation.
View Article and Find Full Text PDFPneumonia is a pathological process of interstitial lung tissue and distal airway and alveolar infection and infiltration. SMART-COP (systolic blood pressure, multilobar infiltrates, albumin, respiratory rate, tachycardia, confusion, oxygen, and pH) is a severity score method designed to identify individuals who require intensive respiratory or vasopressor support (IRVS) support due to pneumonia. Therefore, it is important for management decisions in pneumonia.
View Article and Find Full Text PDFSodium-glucose cotransporter-2 (SGLT2) inhibitors are oral diabetes medications that enhance the excretion of glucose by preventing the renal proximal tubules from reabsorbing glucose, which lowers glucose levels in plasma. Currently, studies have shown that SGLT2 inhibitors have beneficial impacts on cardiovascular outcomes, but their effect varies between the individual SGLT2 inhibitors. Thus, the current meta-analysis was conducted to compare the efficacy of dapagliflozin and empagliflozin in preventing cardiovascular events in patients with type 2 diabetes.
View Article and Find Full Text PDFBackground And Aims: Testosterone supplementation therapy (TST) is a longstanding treatment for hypogonadal men with type 2 diabetes mellitus (T2DM), even though the benefits of TST are variable among trials. This meta-analysis was done to determine the specific role of TST in hypogonadal men with T2DM.
Methods: PubMed, Embase, and Google Scholar were queried to discover eligible randomized controlled trials (RCTs) and observational studies.
Coronary vessel disease (CVD) is a class of diseases that impacts the blood vessels and heart and is one of the leading causes of disability and death. CVD includes cerebrovascular disease and coronary heart disease, both illnesses of the vessels transporting the oxygenated blood to the brain or heart. Colchicine is an inexpensive and old drug with strong anti-inflammatory effects.
View Article and Find Full Text PDF